Tag: Leukemia
-
Biologics development: First leukemia patient given base-edited CAR T cells
base-edited T-cells via CD7 Chimeric Antigen Receptor (CAR)-T cell therapy was done on a thirteen-year-old patient suffering from relapsed T-cell acute lymphoblastic leukemia (T-ALL) which helped them to achieve remission 28 days later.